Editorials
Intrapulmonary lymph node retrieval: unclear benefit for aggressive pathologic dissection
Translational Lung Cancer Research
2012;
1
(4)
:230-233
.
(13 November 2012)
Gene therapy for lung cancer malignant pleural effusion: current and future nano-biotechnology
Translational Lung Cancer Research
2012;
1
(4)
:234-237
.
(13 November 2012)
Review Articles
MET inhibitors in combination with other therapies in non-small cell lung cancer
Translational Lung Cancer Research
2012;
1
(4)
:238-253
.
(13 November 2012)
Potential toxicities of prophylactic cranial irradiation
Translational Lung Cancer Research
2012;
1
(4)
:254-262
.
(13 November 2012)
Innovative technologies in thoracic radiation therapy for lung cancer
Translational Lung Cancer Research
2012;
1
(4)
:263-268
.
(13 November 2012)
EGFR-directed monoclonal antibodies in non-small cell lung cancer: how to predict efficacy?
Translational Lung Cancer Research
2012;
1
(4)
:269-275
.
(13 November 2012)
Perspective
Pulmonary adenocarcinoma histology
Translational Lung Cancer Research
2012;
1
(4)
:276-279
.
(13 November 2012)
EGFR TKIs1
Neoadjuvant EGFR TKIs: toward personalized management in non-small-cell lung cancer
Translational Lung Cancer Research
2012;
1
(4)
:280-282
.
(13 November 2012)
The TORCH trial
Translational Lung Cancer Research
2012;
1
(4)
:283-286
.
(13 November 2012)
Expanding options for EGFR targeting in lung cancer
Translational Lung Cancer Research
2012;
1
(4)
:287-288
.
(13 November 2012)
Case Report
Spontaneous bilateral pneumothorax in a patient with metastatic synovial sarcoma while under chemotherapy
Translational Lung Cancer Research
2012;
1
(4)
:289-291
.
(13 November 2012)
Disclosure:
1. The series “EGFR TKIs” was commissioned by the Editorial office, Translational Lung Cancer Research without any sponsorship or funding.
